Bridging evidence gaps in dravet syndrome: real-world safety insights from under-reported antiseizure therapies.

Ferretti A, Riva A, Perilli L, Parisi P, Striano P.

Open source

DOI
10.1080/14740338.2026.2666178
Published
2026-04-28
Container
Expert Opin Drug Saf
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14740338.2026.2666178,
  title = {Bridging evidence gaps in dravet syndrome: real-world safety insights from under-reported antiseizure therapies.},
  author = {Ferretti A and  Riva A and  Perilli L and  Parisi P and  Striano P.},
  year = {2026},
  journal = {Expert Opin Drug Saf},
  doi = {10.1080/14740338.2026.2666178},
  url = {https://doi.org/10.1080/14740338.2026.2666178}
}

RIS

TY  - JOUR
TI  - Bridging evidence gaps in dravet syndrome: real-world safety insights from under-reported antiseizure therapies.
AU  - Ferretti A
AU  -  Riva A
AU  -  Perilli L
AU  -  Parisi P
AU  -  Striano P.
PY  - 2026
JO  - Expert Opin Drug Saf
DO  - 10.1080/14740338.2026.2666178
UR  - https://doi.org/10.1080/14740338.2026.2666178
ER  - 

APA

A, F., A, R., L, P., P, P., & P., S. (2026). Bridging evidence gaps in dravet syndrome: real-world safety insights from under-reported antiseizure therapies.. Expert Opin Drug Saf. https://doi.org/10.1080/14740338.2026.2666178

Source records